Wednesday, 17 August 2022



LATEST NEWS First Of Its Kind Collaboration (Jashn E Kashmir) Between Punjabi And Kashmiri Artists Pulls Youth In The Valley Secrets: The PropheC Drops Captivating Teaser Of Upcoming Track. Video Inside Andhra Pradesh to get Rs 1.54 lakh cr investment in 2 years Drashti Dhami reveals what made her say yes to 'Duranga' Akshay Kumar grooves to 'Main Khiladi Tu Anari' after 28 years for 'Selfiee' Father's friends rape teenage daughter, one arrested in Kerala Kriti Sanon wants Vijay Devarakonda, Kartik Aaryan, Ryan Gosling in her swayamwar Asaduddin Owaisi slams Centre over targeted killings of Kashmiri Pandits Ireland all-rounder Kevin O'Brien retires from international cricket Basavaraj Bommai supports BJP minister after his 'no functioning govt in Karnataka remark Indices end higher for third straight session, Sensex closes at 58,842 Pulkit Bangia calls 'Kumkum Bhagya' life changing break 'Squid Game' wins two prizes at US critics' awards Prateik Babbar, Simi Chahal's 'Tere Bajjon' is an emotional rollercoaster Nitish Kumar calls 1st cabinet meeting to distribute portfolios to ministers On TV, you just get lost : Aly Goni Ranjit Bawa Is Soon To Hit Music Charts With His Debut EP. Shares Details On IG Stories Adal Badal: After Shershaah, Kiara Advani & Sidharth Malhotra To Share Screen In Upcoming Rom-Com Film Sidharth Malhotra finally reveals his 'future plans' with Kiara on 'Koffee With Karan' Defence Minister Rajnath Singh hands over multiple indigenous weapons to Army Kamal Haasan-starrer 'Vikram' completes 75 days in theatres


Pfizer, BioNTech pick US hospital as trial site for Covid vaccine

Web Admin

Web Admin

5 Dariya News

New York , 26 Aug 2020

University Hospitals (UH) in the US has been selected as the clinical site to test for the Phase 2/3 of a possible Covid-19 vaccine -- BNT162b2 -- sponsored by the US-based pharmaceutical major Pfizer and German biotech firm BioNTech.UH Cleveland medical centre's study site is one of approximately 120 clinical investigational sites around the world that will collectively enrol up to 30,000 participants.This vaccine is one of the most advanced candidates in the BNT162 programme currently being evaluated in the US and Germany and recently received fast track designation from the US Food and Drug Administration (FDA)."We are expecting a shipment of the experimental vaccine and initiation of the trial in the next week," said Daniel I. Simon, MD, Chief Clinical & Scientific Officer and President, UH Cleveland Medical Centre.There is presently no cure for the highly contagious novel coronavirus that causes Covid-19 and the best plan of attack is to find a vaccine that can help protect people from getting it in the first place."The trials we are preparing to conduct are especially significant because if proven safe and effective, and the vaccine receives regulatory approval, Pfizer and BioNTech expect to be able to manufacture up to 100 million doses by the end of 2020," said researcher Robert Salata from UH.The study aims to enrol non-pregnant adults from 18 to 85 years.The trial's primary endpoints will be the prevention of Covid-19 in those who have not been infected by SARS-CoV-2 prior to immunization, and prevention of Covid-19 regardless of whether participants have previously been infected by SARS-CoV-2.The researchers said that secondary endpoints include the prevention of severe Covid-19 in those groups."The goal, as always, is to ensure access to the most novel treatments for our UH patients and the communities we serve," Dr. Simon concluded.Recently, Pfizer and BioNTech announced positive results for the Phase 1 trial of their second Covid-19 vaccine candidate, revealing that the latest vaccine candidate has fewer side effects than their first.


Tags: Coronavirus , COVID 19 , Novel Coronavirus , India Fights Corona , Fight Against Corona , Stay Home Stay Safe , Stay Home , Corona Virus Updates , Social Distancing , Coronavirus Epidemic , Coronavirus Pandemic , Corona virus threat , Corona Outbreak , Pfizer , BioNTech



related news




Photo Gallery



Video Gallery



5 Dariya News RNI Code: PUNMUL/2011/49000
© 2011-2022 | 5 Dariya News | All Rights Reserved
Powered by: CDS PVT LTD